Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Kidney Function Trajectories Before and After HF Hospitalisation
Author(s): Nicolas Girerd Added: 1 year ago
ESC HF 25 - Real-world findings suggest kidney function decline could precede heart failure events by up to a year.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses real-world findings from pooled trials EPHESUS, EMPHASIS-HF and BARCELONA. The study investigated if longitudinal changes in kidney function could help identify patients with HFrEF at a higher risk of… View more

Cardiovascular Kidney Metabolic

Heart Failure
Michael R Zile
Job title: Charles Ezra Daniel Professor of Medicine
Dr. Zile is currently the Charles Ezra Daniel Professor of Medicine and Distinguished University Professor at the Medical University of South Carolina. He is a member of the Cardiology Division at the Ralph H. Johnson Department of Veteran's Affairs Health Care System in Charleston. He is also the Director of the SmartState SC Center of Economic Excellence: Molecular Proteomics in Cardiovascular… View more
HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie
Author(s): Harriette Van Spall , Mark Petrie Added: 2 years ago
HFA 2024 — Join experts, Dr Harriette Van Spall (McMaster University, CA) and Dr Mark Petrie (University of Glasgow, UK) for an insightful wrap up of the novel data presented at 2024's Heart Failure Congress.00:24 - STEP HFpEF Programme: Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF & Semaglutide therapy and diuretic use in obesity-related HFpEF02:20 - EMPACT-MI: The effect of… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
ESC HF 2025 Late-Breaking Science Collection
Author(s): Jasper J Brugts Added: 1 year ago
Watch our video collection following the late-breaking science sessions from the ESC Heart Failure Association's 2025 congress. Our Expert Interviews provide insights on the hottest data and key take-home messages from the most influential trials. View more

MI/ACS

Prevention & Chronic Conditions
Preterm Birth and Maternal Cardiovascular Risk
Author(s): Jorge Segovia-Reyes , Andrea Iboleon-Jimenez , María Jiménez-Salva , et al Added: 1 month ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Author(s): Shelley Zieroth , Gianluigi Savarese , Added: 1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Prof Shelley Zieroth, Dr Shahzeb Khan and Prof Gianluigi Savarese examine the clinical impact of hyperkalemia in heart failure and discuss strategies for its long-term management. View more

Heart Failure
A Spotlight on SGLT2 Initiation in HF Hospitalisation
Author(s): Clara Saldarriaga , David Berg Added: 9 months ago
This webinar series, recorded at the ESC 2025 with key opinion leaders Dr David Berg (Brigham and Women's Hospital, Boston, US) and Dr Clara Saldarriaga (Cardio VID Clinic, Medellin, CO) presenting late-breaking data, explores the evolving evidence for in-hospital initiation of guideline-directed medical therapy after an acute heart failure event. Viewers will gain insight into the persistent… View more

Heart Failure
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Added: 2 years ago Source:  Radcliffe Cardiology
AUTHOR: Jordan Rance; Special Editor: Greg GuilloryA new analysis sheds light on the timing of protection offered by SGLT2 inhibitors. Researchers conducted a cross-trial analysis using individual participant data from four large-scale randomized clinical trials: CANVAS (type 2 diabetes with high atherosclerotic risk, NCT01032629), CREDENCE (diabetic kidney disease, NCT02065791), DAPA-HF (heart… View more

Cardiovascular Kidney Metabolic

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 6 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
Added: 11 months ago Source:  Radcliffe Cardiology
AUTHOR: Jennifer ThomasThe long-standing debate over the benefits of heart rate (HR)-lowering drug treatment, particularly in patients with hypertension, has been addressed in a new large-scale meta-analysis. The findings, published in the European Heart Journal, suggest that the advantages of reducing HR are highly dependent on the patient's underlying clinical condition, with significant… View more

MI/ACS

Prevention & Chronic Conditions